Table 1.
Total cases | n=128 | |
---|---|---|
Site of onset | Bulbar 32 (25%) | Limb 96 (75%) |
Gender | Female 37 (29%) | Male 91 (71%) |
Age at symptom onset (years) | Median 57.0 | IQR 50–64 Range 22–76 |
Diagnostic delay (months) | Median 10.3 | IQR 6.0–15.0 Range 1.0–55.1 |
Riluzole use | Yes 32 (25%) | No 96 (75%) |
Survival from NIV initiation (months) | Median 5.7 | IQR 2.1–11.3 Range 0.1–38.9 |
NIV, non-invasive ventilation.